Home Cart Sign in  
Chemical Structure| 14255-87-9 Chemical Structure| 14255-87-9

Structure of Parbendazole
CAS No.: 14255-87-9

Chemical Structure| 14255-87-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79 nM, and exhibits a broad-spectrum anthelmintic activity.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Parbendazole

CAS No. :14255-87-9
Formula : C13H17N3O2
M.W : 247.29
SMILES Code : O=C(OC)NC1=NC2=CC(CCCC)=CC=C2N1
InChI Key :YRWLZFXJFBZBEY-UHFFFAOYSA-N
Pubchem ID :26596

Safety of Parbendazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Parbendazole

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HN6 126 nM(IC50) 72 hours Inhibition of HNSCC cell proliferation Acta Pharm Sin B. 2022 May;12(5):2429-2442
Primary rat OPCs 0.02 µM 3 days Significantly induced the number of MBP-positive cells EBioMedicine. 2021 Mar;65:103276
Primary rat OPCs 0.02 µM 6 days Significantly increased MOG protein expression EBioMedicine. 2021 Mar;65:103276
CAL-27 270 nM (IC50) 72 hours Inhibition of HNSCC cell proliferation Acta Pharm Sin B. 2022 May;12(5):2429-2442
Fadu 153 nM(IC50) 72 hours Inhibition of HNSCC cell proliferation Acta Pharm Sin B. 2022 May;12(5):2429-2442
Oligodendrocyte precursor cells (OPCs) 0.02 µM 3 days Enhanced MBP and CC1 expression, promoting oligodendrocyte differentiation Int J Mol Sci. 2023 Jun 30;24(13):10972
Human fetal OPCs 0.002 µM and 0.02 µM 4 and 6 days Elevated the percentage of GC-positive cells EBioMedicine. 2021 Mar;65:103276
NG2+ cells 0.02 µM 4 or 8 days Promoted differentiation of NG2+ cells into oligodendrocytes and reduced GFAP expression Int J Mol Sci. 2023 Jun 30;24(13):10972
AML-PDX cells 100 nM 48 hours To evaluate the differentiation-inducing effects of PBZ on AML-PDX cells, results showed PBZ significantly increased monocyte marker expression and induced apoptosis. Commun Biol. 2024 Jan 24;7(1):123
21 AML cell lines 100 nM 48 hours To assess the differentiation-inducing effects of PBZ on various AML cell lines, results showed PBZ significantly increased CD11b and CD14 expression and induced apoptosis. Commun Biol. 2024 Jan 24;7(1):123
THP-1 cells 0.1 µM 48 hours To evaluate the induction of monocytic differentiation in THP-1 cells by PBZ, results showed PBZ significantly increased CD11b and CD14 expression at low concentrations. Commun Biol. 2024 Jan 24;7(1):123
Human mesenchymal stromal cells (hMSCs) 4 µM 7 days To assess alkaline phosphatase activity, mineralization, and bone marker gene expression. Results showed that Parbendazole significantly increased ALP activity, mineralization, and expression of bone marker genes (ALPL, IBSP, SPP1). Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12711-6
Human embryonic lung fibroblasts 0.1 µg/ml 7 days To evaluate the inhibitory effect of Parbendazole on the proliferation of Pneumocystis carinii, results showed Parbendazole effectively inhibited proliferation at 0.1 µg/ml Antimicrob Agents Chemother. 1992 Apr;36(4):779-82

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOG mice AML patient-derived xenograft model Oral 100 mg/kg Once daily for five weeks To evaluate the anti-leukemic effects of PBZ in vivo on AML-PDX cells, results showed PBZ significantly reduced chimerism levels and prolonged mouse survival. Commun Biol. 2024 Jan 24;7(1):123
C57BL/6 mice Cuprizone-induced demyelination model of corpus callosum Intraperitoneal injection 20 mg/kg Daily for 17 days Enhanced spontaneous remyelination, increased PLP-positive area and mature oligodendrocyte numbers EBioMedicine. 2021 Mar;65:103276

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.04mL

0.81mL

0.40mL

20.22mL

4.04mL

2.02mL

40.44mL

8.09mL

4.04mL

References

 

Historical Records

Categories